Economic Burden Of RSV Among High-Risk Adults Is Substantial, Study Indicates

December 28, 2023

Infectious Disease Advisor (12/27, Kuhns) reports, “There was a substantial annual economic burden attributed to respiratory syncytial virus diagnoses among high-risk adults, highlighting the need for preventive interventions such as vaccination.” Notably, the economic burden of RSV “among high-risk adults is substantial, suggesting the need to identify preventive interventions to reduce the effects of severe RSV disease.” The findings were published in the Journal of Infectious Diseases.
PrevNext
April 2025
SuMoTuWeThFrSa
  12345
6789101112
13141516171819
20212223242526
27282930